Barry M,Al Amri M,Memish ZA .2020 .COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia. J Epidemiol Glob Health, 10(1) : 1-3.
Huang C,Wang Y,Li X,Ren L .2020 .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223) : 497-506.
Guan WJ,Ni ZY,Hu Y .2020 .. Clinical characteristics of coronavirus disease 2019 in China N Engl J Med, 382(18) : 1708-20.
Campbell CM,Kahwash R.,Will R. .2020 .Complement inhibition be the new target in treating COVID-19 related systemic thrombosis. Circulation, 141(22) : 1739-41.
Varga Z,Flammer AJ,Steiger P .2020 .Endothelial cell infection and endotheliitis in. COVID-19. Lancet, 395(10234) : 1417-8.
Kloka FA,Kruipb MJ,van NJN .2020 .Incidence of thrombotic complications in critically ill ICU patients with COVID-19. , : 145-47.
Llitjos JF,Leclerc M,Chochois C .2020 .High incidence of venous thromboembolic events in anticoagulated severe COVID-. patients J Thromb Haemost, 18(7) : 1743-6.
Tang N,Li D,Wang X .2020 .Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 18(4) : 844-7.
Cui S,Chen S,Li X .2020 .Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost, 18(6) : 142-24.
Fogarty H,Townsend L,Ni Cheallaigh C .2020 .COVID19 coagulopathy in Caucasian patients. Br J Haematol, 189(6) : 1044-9.
Zhang L,Yan X,Fan Q .2020 .D-dimer levels on admission to predict in-hospital mortality in patients with covid-19. , 18(6) : 1324-9.
Wang T,Chen R,Liu C,Liang W,Guan W,Tang R . .Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.. , : .
.2020 .. Lancet Haematol, 7(5) : e362-3.
Ranucci M,Ballotta A,Di Dedda U .2020 .The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost, 18(7) : 1747-51.
Chen N,Zhou M,Dong X .2020 .Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223) : 507-13.
Wang D,Hu B,Hu C .2020 .Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323(11) : 1061-9.
Zhou F,Yu T,Du R .2020 .Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395(10229) : 1054-62.
Sandersjoo AF,Bellanderab BM .2020 .Is COVID-19 associated thrombosis caused by over activation of the complement cascade? A literature review. Thrombosis Res, (194 : 36-41.
Tang N,Li D,Wang X .2020 .Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 18(4) : 844-7.
.2020 .Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system. Italy. Euro Surveill, 25(19) : 2000620.
Petrilli CM,Jones SA,Yang J . .Factors associated with hospitalization and critical illness among 4103 patients with COVID-19. , : .
.2020 .. Med Rxiv, : .
Libby P,Lüscher T .2020 .-19 is, in the end, an endothelial disease. Eur Heart J, 41(32) : 3038-44.
Iba T,Levy JH,Warkentin TE .2020 .. The unique characteristics of COVID-19 coagulopathy. Critical Care, : 360.
Hoshino K,Kitamura T,Nakamura Y .2017 .Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis. J Intensive Care, 5 : 42.
Taylor FB ,Toh CH,Hoots WK .2001 .Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost, 86(5) : 1327-30.
Levi M,Toh CH,Thachil J .2009 .Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol, 145(1) : 24-33.
RL Bick .2002 .Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost, 8(1) : 1-31.
Gao Y,Li T,Han M .2020 .Diagnostic utility of clinical laboratory data determinations for patients with the severe. COVID-19. J Med Virol, 92(7) : 791-6.
Connors JM,Levy JH .2020 .COVID-19 and its implications for thrombosis and anticoagulation. Blood, 135(23) : 2033-40.
Wu C,Chen X,Cai Y .2020 .Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med, 180(7) : 934-43.
Lippi G,Plebani M,Henry BM .2020 .Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta, 506 : 145-8.
Panigada M,Bottino N,Tagliabue P .2020 .Hypercoagulability of COVID-19 patients in intensive care unit. a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost, 18(7) : 1738-42.
Spiezia L,Boscolo A,Poletto F .2020 .-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost, 120(6) : 998-1000.
Thachil J. .2020 .All those D-dimers in. COVID-19. J Thromb Haemost, 18(8) : 2075-6.